Shukra Pharmaceuticals Limited (BOM:524632)
48.30
-2.54 (-5.00%)
At close: Jan 20, 2026
Shukra Pharmaceuticals Revenue
Shukra Pharmaceuticals had revenue of 75.90M INR in the quarter ending September 30, 2025, with 15.48% growth. This brings the company's revenue in the last twelve months to 362.10M, down -12.24% year-over-year. In the fiscal year ending March 31, 2025, Shukra Pharmaceuticals had annual revenue of 325.87M, down -56.30%.
Revenue (ttm)
362.10M
Revenue Growth
-12.24%
P/S Ratio
52.72
Revenue / Employee
3.15M
Employees
115
Market Cap
19.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 325.87M | -419.86M | -56.30% |
| Mar 31, 2024 | 745.73M | 150.80M | 25.35% |
| Mar 31, 2023 | 594.93M | 390.07M | 190.41% |
| Mar 31, 2022 | 204.86M | 92.90M | 82.97% |
| Mar 31, 2021 | 111.96M | -6.50M | -5.49% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Unichem Laboratories | 22.26B |
| Morepen Laboratories | 17.56B |
| Hikal | 16.99B |
| Gufic Biosciences | 8.74B |
| Bliss GVS Pharma | 8.60B |
| TTK Healthcare | 8.25B |
| Venus Remedies | 6.99B |
| Syncom Formulations (India) | 5.15B |
Shukra Pharmaceuticals News
- 18 days ago - Shukra Pharmaceuticals enters MoU with Borns Medical Robotics to bring AI-powered surgical robots to India and South Asia - Business Upturn
- 7 weeks ago - Shukra Pharma shares jump over 2% after securing authorization to act as DGAFMS distributor across india - Business Upturn
- 7 weeks ago - Shukra Pharmaceuticals receives authorization to act as DGAFMS distributor across india - Business Upturn
- 3 months ago - Shukra Pharmaceuticals enters Robotic Surgery segment with Meril Healthcare authorization - Business Upturn
- 4 months ago - Shukra Pharmaceuticals secures Pan-India distribution rights from Wockhardt - Business Upturn
- 7 months ago - Shukra Pharmaceuticals rises nearly 2% as company opens four new branch offices - Business Upturn
- 7 months ago - Shukra Pharmaceuticals opens new branch offices in Mumbai, Gurgaon, Bangalore, and Kolkata to boost market reach - Business Upturn
- 1 year ago - Shukra Pharmaceuticals shares surge 90% in past one month; Check details - Business Upturn